GlobalData
GlobalData

Medical Devices

Mammography equipment market in South Korea to grow at 4% CAGR through 2036, forecasts GlobalData

The market for mammography equipment in South Korea is undergoing significant growth. This upsurge is attributable to the broadening scope of breast cancer screening initiatives, increased public awareness, and the incorporation of sophisticated imaging technologies. Owing to these factors, the mammography equipment market in South Korea is set to grow at a compound annual growth […]
Read more

US structural heart occlusion market sees early 2025 growth amid trade uncertainty, says GlobalData

The US Structural Heart Occlusion (SHO) market posted a notable 39% year-over-year revenue increase in Q1 2025, amid heightened trade policy uncertainty following President Donald Trump’s re-election and the swift introduction of new tariff measures in early 2025, according to GlobalData, a leading data and analytics company. Trump’s new tariff regime includes a 10% global […]
Read more

Mycobacterium tuberculosis tests market in Japan to grow at 4% CAGR through 2036, forecasts GlobalData

As one of the world’s deadliest infectious diseases, tuberculosis (TB) continues to pose a significant global health challenge, especially in low-resource settings, where the lack of timely, accurate, and accessible diagnostics hampers eradication efforts. Against this backdrop, the Mycobacterium tuberculosis tests market in Japan is projected to achieve substantial growth, with an anticipated compound annual […]
Read more

US medical device companies show diverging paths on tariff strategy, says GlobalData

The Trump administration’s 2025 trade agenda is compelling US medical device companies to address escalating tariff pressures, especially those on imports from China. While some are making decisive shifts in their manufacturing strategies, others are conservatively absorbing short-term impacts and awaiting tariff stabilization. As such, firms must carefully evaluate the long-term risks of trade disruption […]
Read more

US anesthesia and respiratory devices market faces disruption as tariffs drive supply chain shift, says GlobalData

The US anesthesia and respiratory (A&R) devices market faces major disruption as new US tariffs hit foreign-made products, with majority of all 510(k) approved devices manufactured outside the country. This raises serious supply chain concerns and may shift market dynamics in favor of domestic manufacturers, even as the market grows from $4.4 billion in 2023 […]
Read more

Tariffs intensify regulatory pressures for global medical device manufacturers, says GlobalData

As global trade tensions continue to shape the economic landscape, the medical device industry is facing regulatory hurdles tied to shifting tariffs. While tariffs primarily aim to protect domestic industries, their secondary effect is complicating compliance processes and adding pressure to already stringent regulatory pathways, says GlobalData, a leading data and analytics company. When crucial […]
Read more

US diagnostic imaging market faces tariff-driven supply chain and capital risks, reveals GlobalData

The US diagnostic imaging (DI) market is facing growing pressure as new US tariffs raise procurement risks and threaten supply chains. With high-value systems like computed tomography (CT) and magnetic resonance imaging (MRI) heavily reliant on global production, hospitals may delay capital spending amid uncertainty. Although domestic manufacturing offers some short-term protection, extended trade tensions […]
Read more

Trump’s semiconductor tariffs threaten to affect US medical device industry growth, says GlobalData

Donald Trump’s proposed semiconductor tariffs could pose a serious threat to the growth of the US medical device industry, as over half of all devices depend on semiconductors (chips) to operate. With global supply chains under strain and costs rising, especially from Taiwan-based suppliers, the healthcare sector faces looming price increases that may hinder accessibility […]
Read more

Singapore oncology landscape set for disruption with ultrasound-based histotripsy trials, says GlobalData

Singapore’s oncology landscape is set to experience a transformative shift with the introduction of non-invasive, ultrasound-based histotripsy technology, supported by healthcare collaborations aimed at improving outcomes for liver, kidney, and pancreatic cancer patients. These advancements will help Singapore strengthen its position in global cancer research and innovation, says GlobalData, a leading data and analytics company. […]
Read more

Shoulder arthroplasty positioned for substantial growth through innovation and investment, says GlobalData

As the demand for orthopedic solutions grows due to an aging population and an increase in sports-related injuries, investments in advanced arthroplasty systems become increasingly critical. Shoulder arthroplasty has historically lagged behind hip and knee replacements in terms of technological advancement and market penetration. However, recent developments, particularly in implant design and biomechanical optimization, have […]
Read more
1 4 5 6 7 8 50